JPWO2020176776A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020176776A5 JPWO2020176776A5 JP2021550217A JP2021550217A JPWO2020176776A5 JP WO2020176776 A5 JPWO2020176776 A5 JP WO2020176776A5 JP 2021550217 A JP2021550217 A JP 2021550217A JP 2021550217 A JP2021550217 A JP 2021550217A JP WO2020176776 A5 JPWO2020176776 A5 JP WO2020176776A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811511P | 2019-02-27 | 2019-02-27 | |
| US62/811,511 | 2019-02-27 | ||
| PCT/US2020/020175 WO2020176776A1 (en) | 2019-02-27 | 2020-02-27 | Antisense oligomers for treatment of conditions and diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022522205A JP2022522205A (ja) | 2022-04-14 |
| JPWO2020176776A5 true JPWO2020176776A5 (zh) | 2023-03-07 |
Family
ID=72239261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021550217A Pending JP2022522205A (ja) | 2019-02-27 | 2020-02-27 | 病態及び疾患の治療用アンチセンスオリゴマー |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220162605A1 (zh) |
| EP (1) | EP3931329A4 (zh) |
| JP (1) | JP2022522205A (zh) |
| KR (1) | KR20210134003A (zh) |
| CN (1) | CN113748209A (zh) |
| AU (1) | AU2020227825A1 (zh) |
| CA (1) | CA3131591A1 (zh) |
| IL (1) | IL285867A (zh) |
| SG (1) | SG11202109371VA (zh) |
| WO (1) | WO2020176776A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016370653A1 (en) | 2015-12-14 | 2018-06-21 | Cold Spring Harbor Laboratory | Antisense oligomers for treatment of Autosomal Dominant Mental Retardation-5 and Dravet Syndrome |
| EP4303321A2 (en) | 2017-08-25 | 2024-01-10 | Stoke Therapeutics, Inc. | Antisense oligomers for treatment of conditions and diseases |
| EP4069256A4 (en) * | 2019-12-06 | 2023-10-18 | Stoke Therapeutics, Inc. | ANTISENSE OLIGOMERS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS AND OTHER DISEASES |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008546376A (ja) * | 2005-06-16 | 2008-12-25 | バイオノミックス リミテッド | Ｓｃｎ１ａ遺伝子における変異を検出することによっててんかんを診断および処置するための方法 |
| RU2588654C2 (ru) * | 2010-06-23 | 2016-07-10 | Курна, Инк. | Лечение заболеваний, связанных с альфа-субъединицей потенциалзависимого натриевого канала (scna), путем ингибирования природного антисмыслового транскрипта гена scna |
| AU2016370653A1 (en) * | 2015-12-14 | 2018-06-21 | Cold Spring Harbor Laboratory | Antisense oligomers for treatment of Autosomal Dominant Mental Retardation-5 and Dravet Syndrome |
| EP4303321A2 (en) * | 2017-08-25 | 2024-01-10 | Stoke Therapeutics, Inc. | Antisense oligomers for treatment of conditions and diseases |
-
2020
- 2020-02-27 JP JP2021550217A patent/JP2022522205A/ja active Pending
- 2020-02-27 CA CA3131591A patent/CA3131591A1/en active Pending
- 2020-02-27 SG SG11202109371VA patent/SG11202109371VA/en unknown
- 2020-02-27 WO PCT/US2020/020175 patent/WO2020176776A1/en unknown
- 2020-02-27 EP EP20763143.3A patent/EP3931329A4/en active Pending
- 2020-02-27 CN CN202080031771.0A patent/CN113748209A/zh active Pending
- 2020-02-27 KR KR1020217031019A patent/KR20210134003A/ko unknown
- 2020-02-27 AU AU2020227825A patent/AU2020227825A1/en active Pending
-
2021
- 2021-08-25 IL IL285867A patent/IL285867A/en unknown
- 2021-08-26 US US17/412,664 patent/US20220162605A1/en active Pending